BioSig Technologies Inc. (BSGM) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of BioSig Technologies Inc. (BSGM)

The price history of Biosig Technologies (BSGM) reflects the dynamics of an asset valued at 0.00. Biosig Technologies is currently upgrading its PURE EP platform to expand market reach through alliances by 2026. The business relies on creating a cardiology data analysis ecosystem where integrated software and hardware increase switching costs for clinics. Revenue is also generated by ECG noise suppression and sensor maintenance services.

BSGM Biosig Technologies: Long-Term Debt to Equity in the range 07/04/2022 - 09/12/2025

Analytical breakdowns for Biosig Technologies

- share price and consensus valuation forecast:
Price BioSig Technologies|BSGM - Analyst Consensus Forecast
- market capitalization indicators:
Market Value BioSig Technologies, Inc.|BSGM - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share BioSig Technologies|BSGM - Company Book Value|Market Value to Book Value biosig.com|BSGM - Company Total Assets
- debt and solvency information:
Total Debt to Capital Biosig Technologies|BSGM - Long-Term Debt to Equity|Current Liabilities to Equity BioSig|BSGM - Company Aggregate Debts|Debts to Book Value BioSig Technologies, Inc.|BSGM - Company Long-Term Liabilities|Company Short-Term Debts BioSig Technologies|Intermediate Liquidity Ratio biosig.com
- business earnings and investment ratios data:
BSGM - Net Profit
Summary company analysis:BSGM (Biosig Technologies)
Core merchandise of BioSig Technologies

This ratio determines the extent of the company's dependence on long-term borrowings relative to its equity. Analyzing the long-term capital structure indicator allows for an assessment of financial leverage stability over a horizon exceeding one year. The metric compares the total of "long" loans against the base asset value minus liabilities. For Biosig Technologies (BSGM), this is critical, as current deliveries of PUREEP systems generate a moderate cash flow. The stability of this indicator confirms that previous concerns regarding liquidity deficits have been mitigated.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|TELA Bio Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cytosorbents|SRTS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ZYXI|ECOR (electroCore Inc) - Long-Term Debt to Capital|Vicarious Surgical Corp (RBOT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital IINN|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. ICU|Long-Term Debt to Capital IRIX (IRIDEX)|Long-Term Debt to Capital Intelligent Bio Solutions Inc INBS|XAIR - Long-Term Debt to Equity|PFSA: Long-Term Debt to Equity|SSKN (strataskinsciences.com) - Long-Term Debt to Equity Ratio|GlucoTrack Inc. - Long-Term Debt to Capital Coefficient|NAOV (NanoVibronix, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital venusconcept.com VERO|Long-Term Debt to Equity Nuwellis (NUWE)|Aethlon Medical Inc (AEMD) - Long-Term Indebtedness to Equity|Asensus Surgical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Avinger Inc AVGR|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)